Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
51.60
-1.09 (-2.07%)
Oct 21, 2024, 4:00 PM EDT - Market closed

Merus Revenue

Merus had revenue of $7.33M in the quarter ending June 30, 2024, a decrease of -30.01%. This brings the company's revenue in the last twelve months to $35.19M, down -14.63% year-over-year. In the year 2023, Merus had annual revenue of $43.95M with 5.68% growth.

Revenue (ttm)
$35.19M
Revenue Growth
-14.63%
P/S Ratio
84.93
Revenue / Employee
$153,681
Employees
229
Market Cap
3.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202343.95M2.36M5.68%
Dec 31, 202241.59M-7.52M-15.32%
Dec 31, 202149.11M19.16M64.00%
Dec 31, 202029.94M-1.19M-3.82%
Dec 31, 201931.13M-7.25M-18.88%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Haemonetics 1.33B
Prestige Consumer Healthcare 1.11B
HUTCHMED (China) 610.81M
Amicus Therapeutics 455.66M
Axonics 408.81M
ADMA Biologics 330.24M
Alvotech 308.73M
PROCEPT BioRobotics 176.58M
Revenue Rankings